Adoptive transfer of IL‐4 reprogrammed Tc17 cells elicits anti‐tumour immunity through functional plasticity-Reference-Cited by-同舟云学术

Adoptive transfer of IL‐4 reprogrammed Tc17 cells elicits anti‐tumour immunity through functional plasticity

Published:2022-03-31 Issue:3 Volume:166 Page:310-326
ISSN:0019-2805
Container-title:Immunology
language:en
Short-container-title:Immunology

Author:

Liu Chiung‐Hui¹²,Lin Bo‐Shiou³,Wu Mei‐Yao³⁴⁵,Song Ying‐Chyi³⁶,Ke Tao‐Wei⁷⁸,Chou Yu‐Lun³,Liu Chuan‐Teng³,Lin Chia‐Hsin³,Radojcic Vedran⁹,Drake Charles¹⁰¹¹¹²,Yen Hung‐Rong³⁵⁸¹³¹⁴^ORCID

Affiliation:

1. Department of Anatomy, Faculty of Medicine Chung Shan Medical University Taichung Taiwan

2. Department of Medical Education Chung Shan Medical University Hospital Taichung Taiwan

3. Research Center for Traditional Chinese Medicine, Department of Medical Research China Medical University Hospital Taichung Taiwan

4. School of Post‐Baccalaureate Chinese Medicine, College of Chinese Medicine China Medical University Taichung Taiwan

5. Department of Chinese Medicine China Medical University Hospital Taichung Taiwan

6. Graduate Institute of Integrated Medicine, College of Chinese Medicine China Medical University Taichung Taiwan

7. Department of Colorectal Surgery China Medical University Hospital Taichung Taiwan

8. School of Chinese Medicine, College of Chinese Medicine China Medical University Taichung Taiwan

9. Division of Hematology & Hematologic Malignancies, Department of Internal Medicine, Huntsman Cancer Institute University of Utah Salt Lake City Utah USA

10. Columbia Center for Translational Immunology Columbia University Irving Medical Center New York New York USA

11. Department of Urology Columbia University Irving Medical Center New York New York USA

12. Division of Hematology Oncology Columbia University Irving Medical Center New York New York USA

13. Chinese Medicine Research Center China Medical University Taichung Taiwan

14. Department of Laboratory Science and Biotechnology Asia University Taichung Taiwan

Funder

China Medical University Hospital

China Medical University, Taiwan

Huntsman Cancer Foundation

National Heart, Lung, and Blood Institute

Ministry of Health and Welfare

Ministry of Science and Technology, Taiwan

National Health Research Institutes

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imm.13473

Reference60 articles.

1. Cancer immunotherapy: moving beyond current vaccines

2. gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma

3. Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

4. Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1

5. T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conventional T Cell Subsets and Their Roles Within the Tumor Microenvironment;Interdisciplinary Cancer Research;2024

2. CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential;Experimental & Molecular Medicine;2023-11-01

3. RORγT agonists as immune modulators in anticancer therapy.;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11

4. Human in vitro-induced IL-17A+ CD8+ T-cells exert pro-inflammatory effects on synovial fibroblasts;Clinical and Experimental Immunology;2023-06-27

5. Bioinformatics and Raman spectroscopy-based identification of key pathways and genes enabling differentiation between acute myeloid leukemia and T cell acute lymphoblastic leukemia;Frontiers in Immunology;2023-05-17